Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 7, 2016; 22(17): 4307-4320
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4307
Recent developments and innovations in gastric cancer
Mehmet Mihmanli, Enver Ilhan, Ufuk Oguz Idiz, Ali Alemdar, Uygar Demir
Mehmet Mihmanli, Ufuk Oguz Idiz, Uygar Demir, Department of General Surgery, Sisli Etfal Training and Research Hospital, Istanbul 34371, Turkey
Enver Ilhan, Department of General Surgery, Izmir Bozkaya Training and Research Hospital, Izmir 35170, Turkey
Ali Alemdar, Department of General Surgery, Okmeydani Training and Research Hospital, Istanbul 34384, Turkey
Author contributions: Mihmanli M and Ilhan E contributed equally to this work, generated the figures and wrote the manuscript; Idiz UO, Alemdar A, Demir U contributed to the writing of the manuscript; Mihmanli M designed the aim of the editorial and wrote the manuscript.
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Correspondence to: Mehmet Mihmanli, MD, Professor, Department of General Surgery, Sisli Etfal Training and Research Hospital, Halaskargazi caddesi, Istanbul 34371, Turkey.
Telephone: +90-5322853159
Received: January 26, 2016
Peer-review started: January 28, 2016
First decision: March 7, 2016
Revised: March 14, 2016
Accepted: March 30, 2016
Article in press: March 30, 2016
Published online: May 7, 2016
Core Tip

Core tip: Gastric cancers are distinguished from other cancers by their high mortality and morbidity. Many studies have been conducted to improve the quality of life and extend the survival rates of patients, and some of these studies are ongoing. Although promising developments have been made in recent years, the obtained results have limited reliability and benefits. We believe that significant improvements in the treatment of gastric cancer will be developed according to the long-term results of ongoing randomized clinical trials.